InsidersTradesSigma
Follow the 东阿阿胶 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东阿阿胶 has recorded 1 insider filings. Market capitalisation: €34.4bn. The latest transaction was disclosed on 13 July 2023 (Sale). Among the most active insiders: 丁子璇. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€639
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 东阿阿胶 Strong Buy (bullish), based on 8 analysts. Average price target: CN¥75.22.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,243 of 29,064 companies
72.7
score / 100
Value57
Quality88
FCF yld6.4%
Earn yld5.1%
EV/EBITDA15.5x
ROE16%
Gross mgn73%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2023
关于 东阿阿胶
东阿阿胶是一家中国公司，专门生产基于阿胶的保健产品。该公司在深圳证券交易所上市。